Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cancer cells

被引:10
|
作者
Wilsker, Deborah [2 ]
Chung, Jon H. [1 ]
Bunz, Fred [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA
[2] NCI, Mol Radiat Therapeut Branch, SAIC Frederick, Frederick, MD 21701 USA
关键词
p53; Chk1; tetraploid; mitosis; DNA-DAMAGE CHECKPOINT; CHROMOSOMAL INSTABILITY; GENETIC INSTABILITY; KINASE; ATR; PHOSPHORYLATION; PROTEIN; REPLICATION; INACTIVATION; INHIBITION;
D O I
10.4161/cc.19944
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Many cancer cells are unable to maintain a numerically stable chromosome complement. It is well established that aberrant cell division can generate progeny with increased ploidy, but the genetic factors required for maintenance of diploidy are not well understood. Using an isogenic model system derived by gene targeting, we examined the role of Chk1 in p53-proficient and -deficient cancer cells. Targeted inactivation of a single CHK1 allele in stably diploid cells caused an elevated frequency of mitotic bypass if p53 was naturally mutated or experimentally disrupted by homologous recombination. CHK1-haploinsufficient, p53-deficient cells frequently underwent sequential rounds of DNA synthesis without an intervening mitosis. These aberrant cell cycles resulted in whole-genome endoreduplication and tetraploidization. The unscheduled bypass of mitosis could be suppressed by targeted reversion of a p53 mutation or by exogenous expression of Cdk1. In contrast, the number of tetraploid cells was not increased in isogenic cell populations that harbor hypomorphic ATR mutations, suggesting that suppression of unscheduled mitotic bypass is a distinct function of Chk1. These results are consistent with a recently described role for Chk1 in promoting the expression of genes that promote cell cycle transitions and demonstrate how Chk1 might prevent tetraploidization during the cancer cell cycle.
引用
收藏
页码:1564 / 1572
页数:9
相关论文
共 50 条
  • [31] Suppression of autophagy promotes fibroblast activation in p53-deficient colorectal cancer cells
    Inoue, Takanori
    Hayashi, Yoshito
    Tsujii, Yoshiki
    Yoshii, Shunsuke
    Sakatani, Akihiko
    Kimura, Keiichi
    Uema, Ryotaro
    Kato, Minoru
    Saiki, Hirotsugu
    Shinzaki, Shinichiro
    Iijima, Hideki
    Takehara, Tetsuo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] Loss of Histone Deacetylase 4 Causes Segregation Defects during Mitosis of p53-Deficient Human Tumor Cells
    Cadot, Bruno
    Brunetti, Mirko
    Coppari, Sabina
    Fedeli, Silvia
    de Rinaldis, Emanuele
    Dello Russo, Claudio
    Gallinari, Paola
    De Francesco, Raffaele
    Steinkuehler, Christian
    Filocamo, Gessica
    CANCER RESEARCH, 2009, 69 (15) : 6074 - 6082
  • [33] Cadmium (Cd)-induced DNA damage triggers G2/M arrest via chk1/2 and cdc2 in p53-deficient kidney proximal tubule cells
    Lee, Wing-Kee
    Bork, Ulrich
    Kuchler, Anna
    Dittmar, Thomas
    Thevenod, Frank
    FASEB JOURNAL, 2010, 24
  • [34] Cadmium-induced DNA damage triggers G2/M arrest via chk1/2 and cdc2 in p53-deficient kidney proximal tubule cells
    Bork, Ulrich
    Lee, Wing-Kee
    Kuchler, Anna
    Dittmar, Thomas
    Thevenod, Frank
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2010, 298 (02) : F255 - F265
  • [35] XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice
    Yan, Catherine T.
    Kaushal, Dhruv
    Murphy, Michael
    Zhang, Yu
    Datta, Abhishek
    Chen, Changzhong
    Monroe, Brianna
    Mostoslavsky, Gustavo
    Coakley, Kristen
    Gao, Yijie
    Mills, Kevin D.
    Fazeli, Alex P.
    Tepsuporn, Suprawee
    Hall, Giles
    Mulligan, Richard
    Fox, Edward
    Bronson, Roderick
    De Girolami, Umberto
    Lee, Charles
    Alt, Frederick W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (19) : 7378 - 7383
  • [36] Induction of cells with cancer stem cell properties from p53-deficient somatic cells.
    Nishi, Mayuko
    Ryo, Akihide
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [37] Identification of ATR-Chk1 Pathway Inhibitors That Selectively Target p53-Deficient Cells without Directly Suppressing ATR Catalytic Activity
    Kawasumi, Masaoki
    Bradner, James E.
    Tolliday, Nicola
    Thibodeau, Renee
    Sloan, Heather
    Brummond, Kay M.
    Nghiem, Paul
    CANCER RESEARCH, 2014, 74 (24) : 7534 - 7545
  • [38] Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway
    Vitale, Ilio
    Galluzzi, Lorenzo
    Vivet, Sonia
    Nanty, Lisa
    Dessen, Philippe
    Senovilla, Laura
    Olaussen, Ken A.
    Lazar, Vladimir
    Prudhomme, Michelle
    Golsteyn, Roy M.
    Castedo, Maria
    Kroemer, Guido
    PLOS ONE, 2007, 2 (12):
  • [39] Radiosensitization of p53-Deficient Lung Cancer Cells by Pre-treatment with Cytostatic Compounds
    Tokalov, Sergey V.
    Abolmaali, Nasreddin
    ANTICANCER RESEARCH, 2012, 32 (04) : 1239 - 1243
  • [40] Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
    Reaper, Philip M.
    Griffiths, Matthew R.
    Long, Joanna M.
    Charrier, Jean-Damien
    MacCormick, Somhairle
    Charlton, Peter A.
    Golec, Julian M. C.
    Pollard, John R.
    NATURE CHEMICAL BIOLOGY, 2011, 7 (07) : 428 - 430